EXTH-06. CD38-TARGETED THERAPY IN GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) remains a malignancy with a dismal prognosis in spite of current optimal management, including maximal resection, radiation therapy, and alkylating chemotherapy. Relapse is inevitable with the paucity of further effective therapies. The development of novel targeted th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Aulakh, Sonikpreet, Manna, Alak, Schiapparelli, Paula, Ailawadhi, Sikander, Paulus, Aneel, Rosenfeld, Steven, Quinones-Hinojosa, Alfredo, Chanan-Khan, Asher
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216983/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.355
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak